The bile response repressor BreR regulates expression of the Vibrio cholerae breAB efflux system operon.
Enteric pathogens have developed several resistance mechanisms to survive the antimicrobial action of bile. We investigated the transcriptional profile of Vibrio cholerae O1 El Tor strain C6706 under virulence gene-inducing conditions in the presence and absence of bile. Microarray analysis revealed that the expression of 119 genes was affected by bile. The mRNA levels of genes encoding proteins involved in transport were increased in the presence of bile, whereas the mRNA levels of genes encoding proteins involved in pathogenesis and chemotaxis were decreased. This study identified genes encoding transcriptional regulators from the TetR family (vexR and breR) and multidrug efflux pumps from the resistance-nodulation-cell division superfamily (vexB and vexD [herein renamed breB]) that were induced in response to bile. Further analysis regarding vexAB and breAB expression in the presence of various antimicrobial compounds established that vexAB was induced in the presence of bile, sodium dodecyl sulfate, or novobiocin and that the induction of breAB was specific to bile. BreR is a direct repressor of the breAB promoter and is able to regulate its own expression, as demonstrated by transcriptional and electrophoretic mobility shift assays (EMSA). The expression of breR and breAB is induced in the presence of the bile salts cholate, deoxycholate, and chenodeoxycholate, and EMSA showed that deoxycholate is able to abolish the formation of BreR-P(breR) complexes. We propose that deoxycholate is able to interact with BreR and induce a conformational change that interferes with the DNA binding ability of BreR, resulting in breAB and breR expression. These results provide new insight into a transcriptional regulator and a transport system that likely play essential roles in the ability of V. cholerae to resist the action of bile in the host.
Cerda-Maira
Francisca A
FA
Department of Microbiology and Immunology, HB7550, Dartmouth Medical School, Hanover, NH 03755, USA.
Ringelberg
Carol S
CS
Taylor
Ronald K
RK
D000890:Anti-Infective Agents / Q000494:pharmacology; D001426:Bacterial Proteins / Q000235:genetics* / Q000378:metabolism; D001647:Bile Acids and Salts / Q000494:pharmacology*; D002635:Chenodeoxycholic Acid / Q000494:pharmacology; D020355:Cholates / Q000494:pharmacology; D003840:Deoxycholic Acid / Q000494:pharmacology; D024202:Electrophoretic Mobility Shift Assay; D015964:Gene Expression Regulation, Bacterial / Q000187:drug effects*; D008957:Models, Genetic; D009675:Novobiocin / Q000494:pharmacology; D020411:Oligonucleotide Array Sequence Analysis; D009876:Operon / Q000235:genetics; D011401:Promoter Regions, Genetic / Q000235:genetics; D011485:Protein Binding / Q000187:drug effects; D012967:Sodium Dodecyl Sulfate / Q000494:pharmacology; D024363:Transcription Initiation Site; D014734:Vibrio cholerae / Q000235:genetics* / Q000378:metabolism
D000890:Anti-Infective Agents; D001426:Bacterial Proteins; D001647:Bile Acids and Salts; D020355:Cholates; D003840:Deoxycholic Acid; D002635:Chenodeoxycholic Acid; D009675:Novobiocin; D012967:Sodium Dodecyl Sulfate
Gene. 1985;36(1-2):159-67
3934044
J Biol Chem. 2003 Dec 19;278(51):51307-15
14534317
J Bacteriol. 1995 Jul;177(14):4162-5
7608095
Antimicrob Agents Chemother. 1999 Nov;43(11):2624-8
10543738
FEMS Microbiol Rev. 2005 Sep;29(4):625-51
16102595
Antimicrob Agents Chemother. 2005 Mar;49(3):1067-75
15728904
Science. 1994 Apr 15;264(5157):418-20
8153629
Mol Microbiol. 2002 Nov;46(4):1135-47
12421317
J Bacteriol. 2003 Aug;185(16):4825-36
12897002
J Mol Biol. 1983 Sep 25;169(3):707-21
6313933
Arch Microbiol. 2006 Sep;186(3):171-81
16804679
J Biol Chem. 2006 Mar 17;281(11):7102-9
16407274
Antimicrob Agents Chemother. 2003 Oct;47(10):3067-72
14506010
Infect Immun. 1997 Mar;65(3):1131-4
9038330
J Bacteriol. 2005 Nov;187(21):7417-24
16237025
Infect Immun. 2003 Aug;71(8):4250-9
12874300
J Bacteriol. 1999 Jul;181(14):4250-6
10400582
Microbiol Mol Biol Rev. 2005 Jun;69(2):326-56
15944459
J Biol Chem. 1998 Jul 17;273(29):18665-73
9660841
Mol Microbiol. 2006 Jan;59(1):193-201
16359328
Antimicrob Agents Chemother. 1996 Sep;40(9):2021-8
8878574
Antimicrob Agents Chemother. 2002 Jul;46(7):2124-31
12069964
Mol Microbiol. 2001 Jul;41(2):393-407
11489126
J Bacteriol. 2001 Mar;183(6):2025-31
11222601
Mol Microbiol. 1996 Jan;19(1):101-12
8821940
J Bacteriol. 1999 Mar;181(5):1508-14
10049382
Mol Microbiol. 1999 Aug;33(3):651-8
10417654
Infect Immun. 2000 Mar;68(3):1491-7
10678965
Infect Immun. 2001 Jul;69(7):4681-5
11402016
J Biol Chem. 2001 Jan 12;276(2):1479-85
11050092
J Bacteriol. 2004 Oct;186(20):6809-14
15466033
Gene. 1996 Feb 22;169(1):47-52
8635748
Proc Natl Acad Sci U S A. 1988 Dec;85(23):8998-9002
2461560
Microbiol Mol Biol Rev. 2002 Dec;66(4):671-701, table of contents
12456787
Mol Microbiol. 1998 Jan;27(1):63-72
9466256
J Bacteriol. 1996 Oct;178(19):5803-5
8824631
Proc Natl Acad Sci U S A. 1990 Dec;87(24):9898-902
2124707
Science. 2005 Oct 28;310(5748):670-4
16223984
Drugs. 2004;64(2):159-204
14717618
Mol Microbiol. 1995 Apr;16(1):45-55
7651136
Microbiol Immunol. 1986;30(11):1075-83
3543624
Mol Microbiol. 2005 Jul;57(2):420-33
15978075
J Mol Biol. 2005 Jun 3;349(2):387-400
15890203
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10220-4
10944196
FEMS Microbiol Lett. 1996 Jan 15;135(2-3):161-7
8595853
J Bacteriol. 2004 Sep;186(17):5640-8
15317768
Antimicrob Agents Chemother. 2000 Sep;44(9):2242-6
10952562
Microbes Infect. 2000 Jul;2(8):907-13
10962274
Microbiology (Reading). 2004 Apr;150(Pt 4):775-783
15073288
J Bacteriol. 1995 Jul;177(14):4121-30
7608087
Mol Microbiol. 2004 Jul;53(2):697-706
15228545